Injection to reduce repeat strokes from narrowed arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new medication called ongericimab, given as an injection, to see if it lowers the chance of having another stroke. It is for people who recently had a stroke caused by a blocked artery in the brain or neck and who have higher cholesterol levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had an ischemic stroke (a stroke from a blocked blood vessel) within the last 3 months, and you are not severely disabled from it.
- You have at least 50% narrowing in a major artery in your brain or neck, and this narrowing is linked to your recent stroke.
- Your LDL cholesterol ('bad' cholesterol) is at least 70 mg/dL (1.8 mmol/L).
- You have never had a bleeding stroke, and you don't have certain other serious brain conditions.
- Your stroke was not caused by a heart problem like atrial fibrillation, a heart valve issue, or certain other conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This clinical trial tests whether a new cholesterol-lowering medicine can reduce the risk of another stroke in people who recently had a stroke or mini-stroke caused by a narrowed artery in the brain. The study compares the new medicine to a placebo (a dummy pill) to see if it helps prevent future problems.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This study tests a medication called alirocumab (given as an injection) to see if it can stabilize the fatty buildup (plaque) in the carotid artery that caused your recent stroke or mini-stroke. It might help reduce the risk of another event.
This trial tests whether a cholesterol-lowering medicine (called a PCSK9 inhibitor) can help people who recently had a stroke caused by a narrowed artery in the brain. The goal is to see if it reduces the risk of another stroke or helps recovery.
This trial tests whether quickly starting an aggressive cholesterol-lowering treatment after a stroke improves recovery. It is for people who are about to have a procedure to remove a large blood clot from their brain.
Hear when a new Ischemic Cerebral Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.